FIGHT study demonstrates type-2 diabetes therapy ineffective in the treatment of high-risk heart failure patients
Monday, November 9, 2015 - 19:14
in Health & Medicine
In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.